Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
20%
OVERLAP
BY WEIGHT
25
# OF OVERLAPPING
HOLDINGS
XBI
122
HOLDINGS
21%
ALSO IN CANC
CANC
51
HOLDINGS
49%
ALSO IN XBI
SECTOR DRIFT (XBI minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
REVOLUTION MEDICINES, INC. | 2.0% | 7.2% | 2.0% |
|
ABBVIE INC | 1.8% | 2.5% | 1.8% |
|
AMGEN INC | 1.8% | 1.8% | 1.8% |
|
GILEAD SCIENCES INC | 1.8% | 2.5% | 1.8% |
|
EXELIXIS INC | 1.8% | 2.8% | 1.8% |
XBI Overweight Relative to CANC
|
CRISPR THERAPEUTICS AG | 2.2% |
|
IONIS PHARMACEUTICALS, INC. | 1.9% |
|
INSMED INC | 1.9% |
|
EXACT SCIENCES CORP | 1.9% |
|
UNITED THERAPEUTICS CORP | 1.8% |
|
VERTEX PHARMACEUTICALS INC | 1.8% |
|
NATERA INC | 1.8% |
|
MODERNA, INC. | 1.8% |
|
AVIDITY BIOSCIENCES INC | 1.7% |
|
ALNYLAM PHARMACEUTICALS INC | 1.7% |
XBI Underweight Relative to CANC
 |
GENMAB A/S SPONSORED ADR | -5.2% |
|
REVOLUTION MEDICINES, INC. | -5.2% |
|
ELI LILLY & CO | -5.1% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | -4.5% |
|
NOVARTIS AG | -4.2% |
 |
ASTRAZENECA PLC | -4.1% |
|
ARCELLX, INC. | -2.9% |
|
NUVALENT, INC. CLASS A | -2.7% |
 |
MERUS N.V. | -2.7% |
|
BEIGENE LTD. SPONSORED ADR | -2.6% |